Physician profile
Arthur Gumer
NPI 1346238037
$2,374.73
in general payments reported to CMS, 2019-2025
36 companies · $99.51 in 2025
The $99.51 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $241 · 2021: $390 · 2022: $570 · 2023: $294 · 2024: $318 · 2025: $99.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.22 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $454.76 | 2019-2023 | |
| Astellas Pharma US INC | $248.24 | 2022-2024 | Veozah, Myrbetriq |
| Avion Pharmaceuticals | $152.94 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $128.11 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $97.85 | 2024-2025 | |
| Evofem Biosciences, INC. | $94.69 | 2022-2025 | Phexxi, Solosec, Phexx |
| Aspira Women'S Health INC | $93.13 | 2022 | |
| Scynexis, INC. | $90.41 | 2022 | |
| Pfizer INC. | $88.29 | 2019-2023 | |
| Myovant Sciences INC. | $84.37 | 2021 | |
| Millicent US INC | $83.10 | 2024 | Intrarosa |
| Coopersurgical, INC. | $80.03 | 2021-2023 | Wallach Cryosurgical Equipment |
| Allergan, INC. | $79.35 | 2019-2020 | |
| Therapeuticsmd, INC. | $59.13 | 2019-2021 | |
| Agile Therapeutics, INC. | $51.87 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $50.15 | 2021-2022 | |
| Hologic Sales and Service, LLC | $39.98 | 2024-2025 | Aptima |
| Sumitomo Pharma America, INC. | $38.16 | 2023-2024 | Myfembree |
| Coloplast Corp | $37.96 | 2022 | |
| Convatec INC. | $37.54 | 2021 | |
| Amag Pharmaceuticals, INC. | $26.76 | 2019 | |
| Shield Therapeutics INC | $25.60 | 2023 | Accrufer |
| Biohaven Pharmaceutical Holding Company Ltd. | $24.49 | 2022 | |
| Medline Industries Lp | $21.50 | 2025 | |
| Duchesnay USA Incorporated | $19.72 | 2019 | |
| Ascend Therapeutics US, LLC | $18.18 | 2021 | |
| Organon LLC | $17.32 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.26 | 2019 | |
| Shire North American Group INC | $16.32 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.16 | 2021 | |
| Merck Sharp & Dohme LLC | $15.90 | 2024 | Gardasil, Gardasil 9 |
| Currax Pharmaceuticals LLC | $14.08 | 2021 | |
| Amgen INC. | $13.87 | 2019 | |
| Roche Diagnostics Corporation | $13.56 | 2019 | |
| Medicem INC. | $12.15 | 2020 | |
| Dysis Medical, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Gumer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.